Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats

Hypertension

Volumn 46, Issue 4, 2005, Pages 719-724

  Xu, Jinglan ^a,b   Nagata, Kohzo ^c   Obata, Koji ^a   Ichihara, Sahoko ^d   Izawa, Hideo ^b   Noda, Akiko ^c   Nagasaka, Tetsuro ^b   Iwase, Mitsunori ^e   Naoe, Tomoki ^b   Murohara, Toyoaki ^b   Yokota, Mitsuhiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d MIE UNIVERSITY   (Japan)

^e TOYOTA MEMORIAL HOSPITAL   (Japan)

Author keywords

Endothelial growth factors; Fibroblast growth factor; Heart failure; Potassium channels

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DAHL SALT; DRUG VEHICLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NICORANDIL; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CAPILLARY; HEART VENTRICLE HYPERTROPHY; HIGH SODIUM INTAKE; HYPERTENSION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIES; CAPILLARIES; CORONARY VESSELS; ECHOCARDIOGRAPHY; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HYPERTENSION; MALE; MYOCARDIUM; NICORANDIL; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED DAHL; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SODIUM CHLORIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

EID: 31944447600     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000185189.46698.15     Document Type: Article

References (36)

1. Lefer DJ, Lefer AM. Studies on the mechanism of the vasodilator action of nicorandil. Life Sci. 1988;42:1907-1914.
2. Holzmann S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil. J Cardiovasc Pharmacol. 1983;5:364-370.
3. The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269-1275.
4. Kamijo T, Kamei K, Sugo I, Kamiyama T, Sudo H, Ohba Y. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin. J Cardiovasc Pharmacol. 1999;33:93-101.
5. Tice FD, Jungbluth GL, Binkley PF, MacKichan JJ, Mohrland JS, Wolf DL, Leier CV, Bindley PF. Clinical pharmacology of nicorandil in patients with congestive heart failure. Clin Pharmacol Ther. 1992;52:496-503.
6. Yokota M, Horisawa T, Iwase M, Miyahara T, Yoshida J, Kamihara S, Noda S, Tsunekawa A, Koide M, Tsuzuki M. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction. J Cardiovasc Pharmacol. 1987;10:S116-S122.
7. Izawa H, Iwase M, Takeichi Y, Somura F, Nagata K, Nishizawa T, Noda A, Murohara T, Yokota M. Effect of nicorandil on left ventricular end-diastolic pressure during exercise in patients with hypertrophic cardiomyopathy. Eur Heart J. 2003;24:1340-1348.
8. Shimizu T, Okamoto H, Chiba S, Matsui Y, Sugawara T, Akino M, Nan J, Kumamoto H, Onozuka H, Mikami T, Kitabatake A. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res. 2003;58:203-212.
9. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442-447.
10. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A. 1986;83:7297-7301.
11. Tomanek RJ, Sandra A, Zheng W, Brock T, Bjercke RJ, Holifield JS. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ Res. 2001;88:1135-1141.
12. 188. Nat Med. 1999;5:495-502.
13. Torry RJ, O'Brien DM, Connell PM, Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol. 1992;262:H980-H986.
14. Hudlicka O, Tyler KR. The effect of long-term high frequency stimulation on capillary density and fibre types in rabbit fast muscle. J Physiol (Lond). 1984;353:435-445.
15. Gloe T, Sohn HY, Meininger GA, Pohl U. Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via αvβ3. J Biol Chem. 2002;277:23453-23458.
16. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4-25.
17. Horinaka S, Kobayashi N, Higashi T, Hara K, Hara S, Matsuoka H. Nicorandil enhances cardiac endothelial nitric oxide synthase expression via activation of adenosine triphosphate-sensitive K channel in rat. J Cardiovasc Pharmacol. 2001;38:200-210.
18. Iwase M, Yokota M, Kitaichi K, Wang L, Takagi K, Nagasaka T, Izawa H, Hasegawa T. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. Crit Care Med. 2001; 29:609-617.
19. Xu JL, Lai R, Kinoshita T, Nakashima N, Nagasaka T. Proliferation, apoptosis and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytologic grade. J Clin Pathol. 2002;55:530-534.
20. Zheng W, Weiss RM, Wang X, Zhou R, Arlen AM, Lei L, Lazartigues E, Tomanek RJ. DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol. 2004;286:H1994- H2000.
21. 2+-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation. 2001;104:658-663.
22. Inoue K, Sakurada Y, Murakami M, Shirota M, Shirota K. Detection of gene expression of vascular endothelial growth factor and flk-1 in the renal glomeruli of the normal rat kidney using the laser microdissection system. Virchows Arch. 2003;442:159-162.
23. Ziada AM, Hudlicka O, Tyler KR, Wright AJ. The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res. 1984;18:724-732.
24. Chen Y, Torry RJ, Baumbach GL, Tomanek RJ. Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am J Physiol Heart Circ Physiol. 1994;267:H2132-H2137.
25. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242-248.
26. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, Haas TL. Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol. 2002;283:H1430-H1438.
27. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J-24J.
28. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci. 2002;71:2083-2103.
29. Gu JW, Brady AL, Anand V, Moore MC, Kelly WC, Adair TH. Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells. Am J Physiol. 1999;277:H595-H602.
30. Zhao X, Lu X, Feng Q. Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. Am J Physiol. 2002;283:H2371-H2378.
31. Kroll J, Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem. 1997;272:32521-32527.
32. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 1997;272:23659- 23667.
33. 1, and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res. 2000;87:644-647.
34. Toyota E, Matsunaga T, Chilian WM. Myocardial angiogenesis. Mol Cell Biochem. 2004;264:35-44.
35. Singh TM, Abe KY, Sasaki T, Zhuang YJ, Masuda H, Zarins CK. Basic fibroblast growth factor expression precedes flow-induced arterial enlargement. J Surg Res. 1998;77:165-173.
36. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development in the arterial response to injury. Circulation. 1996;94:1074-1082.